Visual outcome and surgical results in children with Marfan syndrome.


Journal

Clinical & experimental ophthalmology
ISSN: 1442-9071
Titre abrégé: Clin Exp Ophthalmol
Pays: Australia
ID NLM: 100896531

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 07 08 2018
revised: 05 07 2019
accepted: 15 07 2019
pubmed: 22 7 2019
medline: 15 12 2020
entrez: 21 7 2019
Statut: ppublish

Résumé

To determine visual and surgical results in children with Marfan syndrome. Marfan syndrome involves ocular complications which can lead to visual disturbance and amblyopia. Data about the visual and surgical results in children with Marfan syndrome is vital for the clinical management of these patients. Retrospective data analysis. Eighty-two eyes of 41 patients with a genetically proved diagnosis of Marfan syndrome. Medical records of patients with Marfan syndrome were reviewed between 2007 and 2017. Ocular complications, visual acuity (VA) of patients with/without lensectomy and surgical method were evaluated. VA outcomes of patients with Marfan syndrome with/without surgical repair of ectopia lentis. In 27 (66%) of the 41 patients a bilateral subluxation of the lens was visible and 14 (52%) patients received lensectomy. The mean age at initial presentation was 12.3 ± 9 years and mean follow-up was 3 years (range 1-7). VA varied from 1.2 to -0.1 logMAR at first examination. At initial presentation, mean VA was 0.1 ± 0.7 logMAR in patients with a normal lens status (n = 14) and 0.3 ± 0.5 logMAR in patients with subluxation of the lens (n = 27) (P < .01). VA improved from 0.2 ± 0.5 logMAR to 0.1 ± 0.5 logMAR (P = .06) in children with subluxation of the lens who did not need a lensectomy (n = 12) and from 0.5 ± 0.5 logMAR to 0.2 ± 0.5 logMAR (P = .02) in patients who were referred to lensectomy with/without secondary lens implantation. In Marfan syndrome subluxation of the lens was found in the majority of children. Improvement of VA resulted in children with subluxation of the lens and following lensectomy.

Sections du résumé

IMPORTANCE OBJECTIVE
To determine visual and surgical results in children with Marfan syndrome.
BACKGROUND BACKGROUND
Marfan syndrome involves ocular complications which can lead to visual disturbance and amblyopia. Data about the visual and surgical results in children with Marfan syndrome is vital for the clinical management of these patients.
DESIGN METHODS
Retrospective data analysis.
PARTICIPANTS METHODS
Eighty-two eyes of 41 patients with a genetically proved diagnosis of Marfan syndrome.
METHODS METHODS
Medical records of patients with Marfan syndrome were reviewed between 2007 and 2017. Ocular complications, visual acuity (VA) of patients with/without lensectomy and surgical method were evaluated.
MAIN OUTCOME MEASURES METHODS
VA outcomes of patients with Marfan syndrome with/without surgical repair of ectopia lentis.
RESULTS RESULTS
In 27 (66%) of the 41 patients a bilateral subluxation of the lens was visible and 14 (52%) patients received lensectomy. The mean age at initial presentation was 12.3 ± 9 years and mean follow-up was 3 years (range 1-7). VA varied from 1.2 to -0.1 logMAR at first examination. At initial presentation, mean VA was 0.1 ± 0.7 logMAR in patients with a normal lens status (n = 14) and 0.3 ± 0.5 logMAR in patients with subluxation of the lens (n = 27) (P < .01). VA improved from 0.2 ± 0.5 logMAR to 0.1 ± 0.5 logMAR (P = .06) in children with subluxation of the lens who did not need a lensectomy (n = 12) and from 0.5 ± 0.5 logMAR to 0.2 ± 0.5 logMAR (P = .02) in patients who were referred to lensectomy with/without secondary lens implantation.
CONCLUSIONS AND RELEVANCE CONCLUSIONS
In Marfan syndrome subluxation of the lens was found in the majority of children. Improvement of VA resulted in children with subluxation of the lens and following lensectomy.

Identifiants

pubmed: 31325202
doi: 10.1111/ceo.13596
pmc: PMC6973035
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1138-1145

Informations de copyright

© 2019 The Authors. Medical University of Vienna. Clinical & Experimental Ophthalmology published by John Wiley & Sons Australia, Ltd on behalf of Royal Australian and New Zealand College of Ophthalmologists.

Références

J Cataract Refract Surg. 1993 Nov;19(6):787-8
pubmed: 8271179
J AAPOS. 2001 Apr;5(2):70-5
pubmed: 11304812
Ann Hum Genet. 1958 Jul;22(4):289-309
pubmed: 13559881
Br J Ophthalmol. 2009 Oct;93(10):1301-6
pubmed: 19416933
Br J Ophthalmol. 2014 Oct;98(10):1338-42
pubmed: 24831716
Ophthalmology. 1996 Apr;103(4):681-6
pubmed: 8618772
J Cataract Refract Surg. 1995 May;21(3):245-9
pubmed: 7674156
Appl Clin Genet. 2016 May 09;9:55-65
pubmed: 27274304
Acta Ophthalmol. 2017 Mar;95(2):170-174
pubmed: 27535343
Ophthalmologica. 2005 Mar-Apr;219(2):72-9
pubmed: 15802930
Ophthalmology. 2003 Jul;110(7):1344-8
pubmed: 12867389
Am J Ophthalmol. 2014 Nov;158(5):899-904
pubmed: 25127699
Ophthalmology. 1984 Oct;91(10):1238-41
pubmed: 6514288
J Cataract Refract Surg. 1998 Aug;24(8):1039-49
pubmed: 9719962
J Cataract Refract Surg. 2013 Dec;39(12):1904-15
pubmed: 24286841
Arch Ophthalmol. 2010 Jul;128(7):810-8
pubmed: 20457949
Int Ophthalmol. 2017 Aug;37(4):1025-1030
pubmed: 27709371
Am J Ophthalmol. 1996 Feb;121(2):224-6
pubmed: 8623900
J AAPOS. 2005 Jun;9(3):240-2
pubmed: 15956943
Br J Ophthalmol. 1979 Nov;63(11):771-8
pubmed: 315794
Curr Opin Genet Dev. 2007 Jun;17(3):252-8
pubmed: 17467262
J AAPOS. 2014 Apr;18(2):140-6
pubmed: 24698610
Acta Paediatr. 1997 Sep;86(9):947-52
pubmed: 9343273
Mol Vis. 2007 Nov 29;13:2242-7
pubmed: 18087243
J Cataract Refract Surg. 2007 May;33(5):819-24
pubmed: 17466855
BMC Ophthalmol. 2015 Oct 27;15:143
pubmed: 26507387
Clin Exp Ophthalmol. 2019 Dec;47(9):1138-1145
pubmed: 31325202
J Cataract Refract Surg. 2012 Dec;38(12):2139-43
pubmed: 23036355
Trans Am Ophthalmol Soc. 1981;79:684-733
pubmed: 7043871

Auteurs

Sandra Rezar-Dreindl (S)

Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.

Eva Stifter (E)

Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.

Thomas Neumayer (T)

Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.

Andrea Papp (A)

Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.

Andreas Gschliesser (A)

Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.

Ursula Schmidt-Erfurth (U)

Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH